News

Find News

Filter articles

Applied Filters

Showing 1 to 10 of 828 results

India approves COVID-19 vaccines ahead of huge rollout

India05-01-2021Muireann Bolger

India has granted emergency approval to COVID-19 vaccines developed by AstraZeneca and Oxford University and one from the state-run institute Bharat Biotech, ahead of a huge immunisation drive that is planned to begin this week.

Canopy sues GW Pharma over cannabis patent

Canada, US24-12-2020Muireann Bolger

Canadian medical cannabis company Canopy Growth has accused GW Pharma of using a patented technological process to produce its flagship epilepsy treatment, Epidiolex, without authorisation.

Ex-DuPont employee gets 42 months over trade secret theft

24-12-2020Rory O'Neill

A US federal appeals court has upheld a 42-month prison sentence for an ex-employee of DuPont Industrial Biosciences who stole trade secrets from the firm.

Danish university sues Creative Biolabs over ‘antibody pirating’

Denmark, US09-12-2020Sarah Morgan

The University of Southern Denmark has accused biotech Creative Biolabs of infringing its patent-protected monoclonal antibody, HG-HYB 7-5. 

CMA reveals antitrust investigation into Essential Pharma over bipolar drug

UK30-11-2020Muireann Bolger

The UK Competition and Markets Authority is investigating Essential Pharma over suspicions that the pharmaceutical company contravened competition law by proposing to withdraw the supply of Priadel, a lithium-based medication for bipolar disease.

Daiichi and AstraZeneca fight back in cancer drug dispute with Seagen

US18-11-2020

Daiichi Sankyo and AstraZeneca have asked the US District Court for the District of Delaware for a declaration that their breast cancer treatment does not infringe a chemotherapy patent owned by biotechnology company Seagen.

Generics sign patent pool pledge to improve access to COVID-19 treatments

International17-11-2020Muireann Bolger

In response to the surge of COVID-19 infections worldwide, 18 generic drug makers have pledged to join the effort by the Medicines Patent Pool to accelerate global access to effective COVID-19 treatments via a pool for voluntary product licences.

FDA to grant licence to Chinese-owned Advion for COVID-19 diagnostic patent

US13-11-2020

The US Food and Drug Administration will today announce that it plans to grant a Chinese-owned testing company an exclusive worldwide licence for a US government-owned patent covering a diagnostic test for the rapid detection of COVID-19.

EC signs contract with Pfizer to access watershed vaccine

EU12-11-2020Muireann Bolger

The European Commission has approved a fourth contract with pharmaceutical companies Pfizer and BioNTech, following their revelation that they had developed a vaccine that could potentially prevent more than 90% of people from becoming infected by COVID-19.

Novavax seals COVID-19 vaccine deal with Australia

Australia05-11-2020Rory O'Neill

Australia has secured 40 million doses of a COVID-19 vaccine candidate in a deal with US biotechnology company Novavax.

Showing 1 to 10 of 828 results

LSIPR